Denali Therapeutics (NASDAQ:DNLI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Denali Therapeutics (DNLI) operate in?

Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	9.00 / 834.27K
Day Range	- - -
52 Wk Range	14.56 - 33.33
Market Cap	$4.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	6.08%
Days to Cover	11.81

Recent News

Denali Therapeutics Stock Is Sliding After The Bell: Here's Why

Denali Therapeutics shares are moving lower in Thursday's after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued.

Adam Eckert

Biogen Q2 Earnings & Sales Beat, 2024 Guidance Raised

Biogen (NASDAQ: BIIB) reported second-quarter 2024 adjusted earnings per share of $5.28, beating the Zacks Consensus Estimate of $4.00. Earnings rose 31% year over year. Earnings benefited from the sale of one of Biogen's two priority review vouchers (PRV).

Zacks

Recursion to Report Q2 Earnings: What's in the Cards?

We believe that Recursion (NASDAQ: RXRX), a TechBio company that decodes biology and chemistry to industrialize drug discovery, is likely to beat expectations when it reports second-quarter 2024 results.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	9.00 / 834.27K
Day Range	- - -
52 Wk Range	14.56 - 33.33
Market Cap	$4.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	6.08%
Days to Cover	11.81

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Denali Therapeutics (DNLI) stock?

You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.

View our list of the best stock brokerages

Who are Denali Therapeutics (DNLI) competitors?

Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Denali Therapeutics (DNLI) stock?

Denali Therapeutics has a consensus price target of $43.35.

What is the current price for Denali Therapeutics (DNLI)?

The stock price for Denali Therapeutics (NASDAQ: DNLI) is $29.89 last updated November 12, 2024 at 5:01 PM EST.

Does Denali Therapeutics (DNLI) pay a dividend?

There are no upcoming dividends for Denali Therapeutics.

When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?

Denali Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Denali Therapeutics (DNLI) going to split?

There is no upcoming split for Denali Therapeutics.

What sector and industry does Denali Therapeutics (DNLI) operate in?

Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Denali Therapeutics

Denali Therapeutics (DNLI) Forecast